EHS
EHS

Alcresta Therapeutics Announces that RELiZORB® iMMOBILIZED LIPASE CARTRIDGE has been Issued a Permanent Medicare Billing Code (B4105) by the Centers for Medicare and Medicaid Services (CMS)



WARREN, N.J.–(BUSINESS WIRE)–Alcresta Therapeutics, Inc. announced the issuance of a permanent and unique billing code by the CMS for RELiZORB.

Source link

EHS
Back to top button